Stockholders' Deficit - Schedule of Warrant Activity (Details) - Warrants [Member] - USD ($) |
12 Months Ended | |
|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Number of shares Outstanding, Beginning | 149,517 | 150,279 |
| Number of shares Issued | 1,064,000 | |
| Number of shares Exercised | (104,762) | |
| Number of shares Forfeited | (960,000) | |
| Number of shares Expired | (4,000) | |
| Number of shares Outstanding, Ending | 145,517 | 149,517 |
| Number of shares Outstanding Exercisable, Ending | 145,517 | |
| Weighted Average Price Per Share Outstanding, Beginning | $ 11.25 | $ 107.50 |
| Weighted Average Price Per Share Issued | 7.99 | |
| Weighted Average Price Per Share Exercised | 3.00 | |
| Weighted Average Price Per Share Expired | 7.50 | |
| Weighted Average Price Per Share Forfeited | ||
| Weighted Average Price Per Share Outstanding, Ending | 11.11 | $ 11.25 |
| Weighted Average Price Per Share Outstanding Exercisable, Ending | $ 11.11 | |
| Weighted average remaining contractual term | 9 months 3 days | |
| Aggregate intrinsic value | ||
| X | ||||||||||
- Definition Number of equity instruments other than options exercisable, including both vested and non-vested instruments. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments issued to participants. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Outstanding Exercisable, Ending. No definition available.
|
| X | ||||||||||
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Non-options Equity Instruments, Weighted Average. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Exercised. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Expired. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Price Per Share Issued. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term. No definition available.
|
| X | ||||||||||
- Definition Aggregate intrinsic value. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|